Despite the fact that Ru complexes may be mimicking Fe uptake and thereby accumulate in cancer cells overexpressing transferrin,92,93 and assuming an intravenous administration, the light-activatable prodrugs presented above are supposed to be transported everywhere in the body without special selectivity for cancer cells. The gene discussed is TF; the disease is cancer.